Standout Papers

Antibody–drug conjugates: in search of partners of choice 2023 2026 2024119
  1. Antibody–drug conjugates: in search of partners of choice (2023)
    Jesús Fuentes‐Antrás, Sofia Genta et al. Trends in cancer

Immediate Impact

1 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Role of SLC7A11/xCT in Ovarian Cancer
2024 Standout
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
1 intermediate paper

Works of Sofia Genta being referenced

Antibody–drug conjugates: in search of partners of choice
2023 Standout
PARP Inhibitors in Ovarian Cancer
2018

Author Peers

Author Last Decade Papers Cites
Sofia Genta 417 278 136 163 36 708
David A. Moore 320 258 115 91 27 690
Sophia Frentzas 366 262 145 114 62 681
Andrea Milani 408 265 204 107 34 746
George Au‐Yeung 432 284 113 72 40 663
Myriam Kossaï 264 273 167 96 36 739
Elena Poddubskaya 435 290 228 122 53 767
Ioannis Zerdes 511 225 179 254 44 818
Chiara Della Pepa 244 196 170 98 22 625
Emma Kipps 287 267 94 123 24 678
Gaia Giannone 328 251 107 149 32 708

All Works

Loading papers...

Rankless by CCL
2026